Use of Pharmacokinetic Modeling to Design Studies for Pathway-Specific Exposure Model Evaluation

Authors:

Abstract
Validating an exposure pathway model is difficult because the biomarker, which is often used to evaluate the model prediction, is an integrated measure for exposures from all the exposure routes and pathways. The purpose of this article is to demonstrate ...

This publication has 19 references indexed in Scilit: